Mycobacteria Infection in Incomplete Transverse Myelitis Is Refractory to Steroids: A Pilot Study
2011

Mycobacteria Infection in Incomplete Transverse Myelitis Is Refractory to Steroids: A Pilot Study

Sample size: 67 publication Evidence: moderate

Author Information

Author(s): Feng Yanqing, Guo Ning, Liu Junxiu, Chen Xi, Sun Qiaosong, Lai Rong, Huang Fan

Primary Institution: The First Affiliated Hospital of Sun Yat-sen University

Hypothesis

Can antituberculous treatment help patients with incomplete transverse myelitis whose condition deteriorates despite steroid treatment?

Conclusion

Antituberculous treatment shows significant clinical benefits for patients with steroid-refractory incomplete transverse myelitis.

Supporting Evidence

  • 49 out of 51 patients showed significant improvement in neurological signs after 24 months of treatment.
  • Patients experienced increased scores on the American Spinal Injury Association and Barthel Index assessments.
  • 16 patients withdrew from the study, primarily due to side effects or perceived lack of efficacy.

Takeaway

This study found that a special medicine for tuberculosis can help people with a serious spinal cord problem when other treatments don't work.

Methodology

This was a prospective, open-label study assessing the efficacy of antituberculous treatment in patients with steroid-refractory incomplete transverse myelitis over 24 months.

Potential Biases

Potential biases due to the open-label design and lack of a control group.

Limitations

The study was uncontrolled and had a small sample size.

Participant Demographics

The study included 67 patients, with 24 males and 43 females, and a median age of 39.07 years.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1155/2011/501369

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication